What’s New With RSV, COVID-19, and Flu Shots for Kids
Stanford Childrens
OCTOBER 16, 2023
Palivizumab is approved for children under 24 months of age with certain conditions that place them at high risk for severe RSV disease. Antibodies are part of our immune system and help us fight infections. This must be given once a month during RSV season.
Let's personalize your content